Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP697323.RAoFZkS4FH60S7QwiZTMVZsQT8b4BMddW2U6BQlmMHMTg130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697323.RAoFZkS4FH60S7QwiZTMVZsQT8b4BMddW2U6BQlmMHMTg130_provenance.
• NP340715.RA4N7FiyfyBmPxWuOf_bWTUqs3J3ym9lO_d9j1dk-m8EY130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340715.RA4N7FiyfyBmPxWuOf_bWTUqs3J3ym9lO_d9j1dk-m8EY130_provenance.
• NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP557150.RAIinQwJ54ZgbGK1ZmHJhzp2nI_qhfIB2JQu15u-hU9BY130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557150.RAIinQwJ54ZgbGK1ZmHJhzp2nI_qhfIB2JQu15u-hU9BY130_provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP984463.RAeHtxV0BJsYulh3RM6r7iLy-wvTuAV9QKpZULpv21Lf0130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984463.RAeHtxV0BJsYulh3RM6r7iLy-wvTuAV9QKpZULpv21Lf0130_provenance.
• NP984464.RAWfiCw_wO8mxHNAo6w-NxGdEKHk5vrCryhqoKE7Zj79o130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984464.RAWfiCw_wO8mxHNAo6w-NxGdEKHk5vrCryhqoKE7Zj79o130_provenance.
• NP468807.RAlwaYMIZ-QTZsfhhcrVutidQFbqCRR3V4uDGnWvP3U1A130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468807.RAlwaYMIZ-QTZsfhhcrVutidQFbqCRR3V4uDGnWvP3U1A130_provenance.
• NP468826.RAsIl1KGLtJ7WO6aLB0CTYp1W2DXwFJBIie4vHairwPbI130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468826.RAsIl1KGLtJ7WO6aLB0CTYp1W2DXwFJBIie4vHairwPbI130_provenance.
• NP812325.RAszCFEpCqfxpUTH4Th0h2oUEc67oNF6IL1T1eGCKjh8w130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812325.RAszCFEpCqfxpUTH4Th0h2oUEc67oNF6IL1T1eGCKjh8w130_provenance.
• NP984465.RAnSIDisJCDT4LaMiZZhaDNaTzJyNXt9eySxkc1EEXCig130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984465.RAnSIDisJCDT4LaMiZZhaDNaTzJyNXt9eySxkc1EEXCig130_provenance.
• NP468488.RAMukYK_cMoTsJphk_bwwWHTzSAYdEV2wSr_RIzbu2-y0130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468488.RAMukYK_cMoTsJphk_bwwWHTzSAYdEV2wSr_RIzbu2-y0130_provenance.
• NP468467.RAxisgfmgl2qEJiQ9Y940io3V1J5xsI716G8lsILUaBhI130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468467.RAxisgfmgl2qEJiQ9Y940io3V1J5xsI716G8lsILUaBhI130_provenance.
• NP984462.RAFiXgh0a8gzIscHMjttokQVTezg2NQ_0wRyF0YA6jp3o130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984462.RAFiXgh0a8gzIscHMjttokQVTezg2NQ_0wRyF0YA6jp3o130_provenance.
• NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
• NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.